title: A randomized, prospective, double-masked clinical trial of Optisol vs DexSol corneal storage media.
abstract: We compared Optisol and DexSol, two chondroitin-sulfate-based media for corneal storage at 4 degrees C, by transplanting 31 donor cornea pairs (one cornea stored in Optisol and its mate in DexSol for 20 to 134 hours) into 31 pairs of recipients (62 patients). All grafts were clear 1 year after transplantation except for one primary donor failure (Optisol group). Optisol-stored corneas were significantly thinner than DexSol-stored corneas after cardinal suture placement (0.64 mm vs 0.76 mm) and at the end of surgery (0.69 mm vs 0.78 mm); at all points afterward through 1 year the two groups did not differ. The activity of two lysosomal enzymes released into the media during storage, alpha-mannosidase and alpha-glucosidase, was lower in the Optisol group. Epithelial status and all endothelial morphometric parameters, except the figure coefficient at 1 year, did not differ between the two groups before surgery and 3, 6, and 12 months after surgery. Mean endothelial cell loss at 1 year was 15% for the Optisol group and 21% for the DexSol group (P = .22). Thus, Optisol-stored corneas were thinner during surgery than DexSol-stored corneas and there was less lysosomal enzyme activity in the Optisol medium after tissue storage. There were no significant differences in postoperative clinical or endothelial morphometric parameters, however.
authors.affiliation: Department of Ophthalmology, Case Western Reserve University, Ohio 44106.
authors.forename: J H
authors.initials: JH
authors.lastname: Lass
authors.forename: W M
authors.initials: WM
authors.lastname: Bourne
authors.forename: D C
authors.initials: DC
authors.lastname: Musch
authors.forename: A
authors.initials: A
authors.lastname: Sugar
authors.forename: J F
authors.initials: JF
authors.lastname: Gordon
authors.forename: W J
authors.initials: WJ
authors.lastname: Reinhart
authors.forename: R F
authors.initials: RF
authors.lastname: Meyer
authors.forename: D I
authors.initials: DI
authors.lastname: Patel
authors.forename: W E
authors.initials: WE
authors.lastname: Bruner
authors.forename: D B
authors.initials: DB
authors.lastname: Cano
mesh_terms: D000328:Adult; D000368:Aged; D002452:Cell Count; D002809:Chondroitin Sulfates; D045424:Complex Mixtures; D003315:Cornea / Q000378:metabolism; D015925:Cryopreservation; D016895:Culture Media, Serum-Free; D003911:Dextrans; D004311:Double-Blind Method; D004728:Endothelium, Corneal / Q000473:pathology; D005260:Female; D005839:Gentamicins; D006085:Graft Survival; D006531:HEPES; D006801:Humans; D015948:Keratoplasty, Penetrating; D008297:Male; D008361:Mannosidases / Q000378:metabolism; D009926:Organ Preservation; D009930:Organic Chemicals; D011446:Prospective Studies; D016896:Treatment Outcome; D000520:alpha-Glucosidases / Q000378:metabolism
chemical_list: D045424:Complex Mixtures; D016895:Culture Media, Serum-Free; C075735:Dexsol; D003911:Dextrans; D005839:Gentamicins; D009930:Organic Chemicals; D002809:Chondroitin Sulfates; C075736:Optisol; D008361:Mannosidases; D000520:alpha-Glucosidases; D006531:HEPES